# Molecular Imaging of Prostate-Specific Membrane Antigen Using Labeled Technetium-99m BQ0413

> **NCT06101927** · PHASE1 · COMPLETED · sponsor: **Tomsk National Research Medical Center of the Russian Academy of Sciences** · enrollment: 10 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Whole body study and SPECT with [99mTc]Tc-BQ0413

## Key facts

- **NCT ID:** NCT06101927
- **Lead sponsor:** Tomsk National Research Medical Center of the Russian Academy of Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-19
- **Primary completion:** 2024-05-31
- **Final completion:** 2024-12-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-04-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06101927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06101927, "Molecular Imaging of Prostate-Specific Membrane Antigen Using Labeled Technetium-99m BQ0413". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06101927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*